NBIX
Neurocrine Biosciences Inc
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Neurocrine Biosciences (NBIX) Stock: Buy, Sell, or Hold?
$169.40
-5.01 (-2.87%)
▼
5d:
+6.03%
30d:
+24.64%
90d:
+10.92%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 02, 2026
0d
Protect NBIX Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (27%)
Quality Score
23/100
Position
EXTENDED
30-Day Fair Range
$137.15 – $160.82
Position: EXTENDED
Forward P/E & Valuation
13.8x
FAIR
vs 13.4x historical avg
Wall Street Target
$208.11
+22.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$143.75 / $174.59
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: NBIX shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When NBIX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$265.02
Based on 10.1% avg growth
INTRINSIC VALUE TODAY
$164.56
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NBIX is currently trading at $169.40, which is considered extended relative to its 30-day fair value range of $137.15 to $160.82. The stock's valuation (Forward PE: 13.8) is in line with its historical norms (13.4). At these levels, the market is pricing in 0.9% annual earnings growth.
Technical Outlook: Technically, NBIX is in a strong downtrend. Immediate support is located at $143.75, while resistance sits at $174.59.
Market Sentiment: NBIX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $208.11 (+22.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NBIX is in a strong downtrend. Immediate support is located at $143.75, while resistance sits at $174.59.
Market Sentiment: NBIX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $208.11 (+22.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$137.15 -
$160.82
Company Quality Score
23/100
(STRONG SELL)
Volume Confirmation
HIGH
Confidence Score
27.1%
Trading Range & Key Levels
30-Day Trading Range
$137.15 -
$160.82
Current vs Trading Range
EXTENDED
Support Level
$143.75
Resistance Level
$174.59
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding NBIX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range (+5.3% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.9% below Wall St target ($208.11)
- BULLISH: Expecting earnings turnaround to 0.9% growth with 41.2% revenue growth
- WARNING: Composite score 23/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
13.77
Wall Street Target
$208.11
(+22.9%)
Revenue Growth (YoY)
41.2%
Earnings Growth (YoY)
-3.9%
Profit Margin
19.0%
Valuation Premium vs History
+0.9% premium
PE vs Historical
13.8 vs 13.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.9%
(market-implied from PE analysis)
1-Year Target
$170.92
(+1%)
2-Year Target
$172.46
(+2%)
3-Year Target
$174.02
(+3%)
3-Yr Target (if PE normalizes)
(PE: 14→13)
PE COMPRESSION
$169.30
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 16.1%)
$382.66
(+126%)
Base:
(SPY PE: 13.8, Growth: 16.1%)
$265.38
(+57%)
Bear:
(PE: 11.7, Growth: 16.1%)
$225.57
(+33%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 25.09 | Current EPS (TTM): $6.95
Bull Case
$339.51
(+100%)
Analyst growth 77.0%, PE expands to 27.6
Base Case
$308.64
(+82%)
Market implied 77.0%, PE stable at 25.1
Bear Case
$118.60
(-30%)
Severe decline -20.0%, PE contracts to 21.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share NBIX Analysis
Share this live NBIX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NBIX)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits shows 100.0% bullish sentiment towards $NBIX with traders expressing optimism about the company's energy and product pipeline.
Key Retail Themes:
Positive sentiment towards $NBIX's energy sector involvement
Excitement for the company's product pipeline
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 3:32 AM ET
Data refreshes hourly during market hours. Next update: 4:32 AM
Data refreshes hourly during market hours. Next update: 4:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NBIX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 41 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 60 BUY |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 36 SELL |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 51 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$687 | 43 HOLD |
Advanced NBIX Option Strategies
Professional options setups generated by AI based on today's NBIX price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NBIX Research Pages
